MONOVISC®


MONOVISC®
Europe
  • Manufacturer : Anika Therapeutics
  • Active Substance(s) : Sodium hyaluronate
  • Strength : 22mg/ml
  • Pack Size : 1-4ml prefilled syringe
  • Accessories: Package insert
  • B - Brand Name
MONOVISC® 4ml 1 prefilled syringe
MONOVISC® 4ml 1 prefilled syringe MONOVISC® 4ml 1 prefilled syringe MONOVISC® 4ml 1 prefilled syringe
1 - 5 pack(s) - $349.00 USD
6 - 10 pack(s) - $339.00 USD
11 - 20 pack(s) - $334.00 USD
21+ pack(s) - USD$329 329USD
Add
units to my shopping cart.
Save $60.00 if you add 5 additional units.
MONOVISC® Non-English
Europe
  • Manufacturer : Anika Therapeutics
  • Active Substance(s) : Sodium hyaluronate
  • Strength : 22mg/ml
  • Pack Size : 1-4ml prefilled syringe
  • Accessories: Package insert
  • B - Brand Name
MONOVISC® Non-English 22mg/ml 1-4ml prefilled syringe
MONOVISC® Non-English 22mg/ml 1-4ml prefilled syringe MONOVISC® Non-English 22mg/ml 1-4ml prefilled syringe MONOVISC® Non-English 22mg/ml 1-4ml prefilled syringe

Sorry, this item is out of stock

Product Specifications

Product Name: MONOVISC®.
Active composition: Cross-Linked Sodium Hyaluronate, 22mg/ml.
Form & Contents: 1x4mL pre-filled syringe.
Manufacturer: Anika Therapeutics, Inc.
Origin: Europe.
Accessory: Package leaflet only. A set of patients label is provided to ensure traceability.
Storage Conditions: It should be stored at 2℃ to 25℃. Protect from freezing.
Note: Sterile packaging.

Product Information

Monovisc is an injectable viscosupplement made of non-avian hyaluronan. Purchase Monovisc from Medical Device Source to help your patients find relief from their osteoarthritis pain. The Monovisc gel is a medical device made of high molecular weight hyaluronan, otherwise known as hyaluronic acid. This hyaluronan comes from bacterial fermentation in the laboratory, not from chicken combs like some other viscosupplements, so it is safe for patients who have avian allergies. The hyaluronan in Monovisc is also ultra-pure for maximum effectiveness. Because Monovisc contains a high concentration of hyaluronan, it can give your patients relief from osteoarthritis symptoms with just one injection, instead of a set of three to five injections. This can be more convenient for patients as they get one single Monovisc injection about every six months for continuous osteoarthritis relief. Monovisc, which is the single-injection version of Orhtovisc, works by providing lubrication and cushioning to the joint. Aging along with obesity and injury can increase osteoarthritis damage in the knee or other joints, with the joint's protective cartilage breaking down. This can also be associated with degradation of the synovial fluid in the joint. As the joint loses its lubrication and protection, the ends of the bones can rub against each other, causing pain and loss of movement. Monovisc works by adding a higher quality fluid to the knee joint. As you inject Monovisc directly into the knee joint, the hyaluronan gel provides lubrication and cushioning to the joint so the bone ends cannot rub together. This helps in turn to reduce knee pain and increase joint movement. Monovisc injections provide an alternative to, or a complement to, other osteoarthritis treatments like pain relievers that may not be providing osteoarthritis relief any longer.

Injections of Monovisc can cause side effects like pain at the injection site, joint pain, joint swelling, and joint effusion. You should not inject Monovisc into joints that have an infection, into skin that has a disease, or into patients that have a systemic bleeding disorder. You should tell your patients to avoid bearing weight or participating in strenuous activities, such as tennis, jogging, or other sports, for about forty-eight hours after their Monovisc injection. The hyaluronan in Monovisc does not come from animals, but actually from bacteria, so it is safe for your patients who are allergic to eggs, feathers, and poultry. However, you should not inject patients with Monovisc who are allergic to hyaluronan or to gram-positive bacterial proteins.

Monovisc is a non-drug therapy so it offers an alternative to pain-killers for osteoarthritis relief. Injections of Monovisc cushion, lubricate, and protect the knee joint by restoring the knee's natural joint fluid. The advantage of Monovisc over other viscosupplements is that it treats osteoarthritis with just one injection every six months, instead of the usual set of three to five hyaluronan injections that the patient gets weekly. This makes Monovisc injections more convenient for many patients. Purchase Monovisc from Medical Device Source to help patients find osteoarthritis relief.

Home | FAQ | Contact Us | Terms and Conditions | Privacy Policy | Refunds, Cancellation and Shipping Policy

Copyright © 2002-2020

MedicalDeviceSource.com is not affiliated with or endorsed by the manufacturers of these products. All products are genuine, and brand trademarks are owned solely by their respective manufacturers. Please note that product packaging may appear different than images shown here.